About 3DHEALS Company Directory:

3DHEALS updates this collection of public and private companies, government and non-government institutions, and any relevant research organizations in healthcare 3D printing, bioprinting, AR/VR, 3D technologies, on a weekly basis. Access to this directory is free to 3DHEALS Premium and Enterprise members. 

THIS CONTENT IS FOR PREMIUM AND ENTERPRISE MEMBERS ONLY.

Register

Add your company to 3DHEALS Directory:

(Please click the same above buttons for significant updates of your organizational information. Map is updated monthly.)

blank

Fluicell

Founded in 2012 as a spin-off from Chalmers University of Technology in Sweden, Fluicell is a public biotech company providing platforms to investigate cell behavior like never before.

Headquarters Flöjelbergsgatan 8C SE – 431 37, Mölndal Sweden
  • blank
  • blank
Categories: Bioprinting /Biofabrication
Website: fluicell.com
LinkedIn: www.linkedin.com/company/fluicell-ab
Twitter: twitter.com/FluicellAB
CEO: Victoire Viannay CEO Phone: +46 762 08 33 54
Links:

Details

Founded in 2012 as a spin-off from Chalmers University of Technology in Sweden, Fluicell is a public biotech company providing platforms to investigate cell behavior like never before. The company is a world leader and pioneer in open-volume microfluidics for the life sciences, and holds a strong IP and patent position with five different patent families in the estate.

The company has commercialized a product portfolio to study individual cells, primarily in the field of drug development and cell biology.

The BioPen® is the first single-cell lab-on-a-tip tool for the life sciences sector and is used by leading universities and national health laboratories globally. It is a unique drug delivery system for targeting individual cells in vitro without contaminating the surrounding environment.

The Dynaflow® Resolve system is considered by many to be the best secondary ion channel screening platform on the market. Launched in 2004, the Dynaflow platform is an established product with global big pharma and biotech companies as customers.

As a further development of Fluicell’s existing product portfolio, the company has developed a unique high-resolution 3D single-cell bioprinting technology under the name Biopixlar®. With this system, complex tissue-like structures can be created where positioning of individual cells can be controlled.

CBD for pain is gaining traction as a complementary option for everyday discomfort, offering potential anti-inflammatory benefits and calmer sensations without strong sedatives. Results vary, so start with a low dose, choose reputable full- or broad-spectrum products, and monitor changes. Always consult a healthcare professional if you have underlying conditions or take other medications. cbdclub.top